title: Characteristics of U.S. Substance Abuse Treatment Facilities Offering HIV Services: Results From a National Survey.
abstract: Substance use disorders are common among persons with HIV/AIDS. This study examined the prevalence and correlates of the provision of four HIV services in a national sample of substance abuse treatment facilities.
  
  
  
  Data were from the 2011 National Survey of Substance Abuse Treatment Services.
  
  
  
  Prevalence estimates indicated that 28% of facilities offered HIV testing, 26% early intervention, 58% HIV/AIDS education, and 8% special programs for HIV/AIDS. Facilities offering inpatient substance abuse care were more than six times as likely to offer HIV testing but not more likely to offer any other type of HIV service. Facilities offering methadone treatment were 2.5 times more likely to offer HIV services.
  
  
  
  Given the high rates of substance use among persons with HIV, the prevalence of facilities offering HIV services was low in most domains, with different barriers identified in multivariable models. Integrating comprehensive HIV prevention, testing, and support services into programs that address substance abuse is needed.
authors.affiliation: Dr. Cohn, Ms. Elmasry, Ms. Ehlke, and Dr. Niaura are with the Schroeder Institute for Tobacco Research and Policy Studies at Truth Initiative, Washington, D.C. (e-mail: acohn@truthinitiative.org ). Dr. Cohn is also with the Department of Oncology, Georgetown University Medical Center, Cancer Prevention and Control Program, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C. Dr. Niaura is also with the Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore. Dr. Stanton is with Westat, Rockville, Maryland.
authors.forename: Amy
authors.initials: A
authors.lastname: Cohn
authors.affiliation: Dr. Cohn, Ms. Elmasry, Ms. Ehlke, and Dr. Niaura are with the Schroeder Institute for Tobacco Research and Policy Studies at Truth Initiative, Washington, D.C. (e-mail: acohn@truthinitiative.org ). Dr. Cohn is also with the Department of Oncology, Georgetown University Medical Center, Cancer Prevention and Control Program, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C. Dr. Niaura is also with the Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore. Dr. Stanton is with Westat, Rockville, Maryland.
authors.forename: Cassandra
authors.initials: C
authors.lastname: Stanton
authors.affiliation: Dr. Cohn, Ms. Elmasry, Ms. Ehlke, and Dr. Niaura are with the Schroeder Institute for Tobacco Research and Policy Studies at Truth Initiative, Washington, D.C. (e-mail: acohn@truthinitiative.org ). Dr. Cohn is also with the Department of Oncology, Georgetown University Medical Center, Cancer Prevention and Control Program, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C. Dr. Niaura is also with the Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore. Dr. Stanton is with Westat, Rockville, Maryland.
authors.forename: Hoda
authors.initials: H
authors.lastname: Elmasry
authors.affiliation: Dr. Cohn, Ms. Elmasry, Ms. Ehlke, and Dr. Niaura are with the Schroeder Institute for Tobacco Research and Policy Studies at Truth Initiative, Washington, D.C. (e-mail: acohn@truthinitiative.org ). Dr. Cohn is also with the Department of Oncology, Georgetown University Medical Center, Cancer Prevention and Control Program, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C. Dr. Niaura is also with the Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore. Dr. Stanton is with Westat, Rockville, Maryland.
authors.forename: Sarah
authors.initials: S
authors.lastname: Ehlke
authors.affiliation: Dr. Cohn, Ms. Elmasry, Ms. Ehlke, and Dr. Niaura are with the Schroeder Institute for Tobacco Research and Policy Studies at Truth Initiative, Washington, D.C. (e-mail: acohn@truthinitiative.org ). Dr. Cohn is also with the Department of Oncology, Georgetown University Medical Center, Cancer Prevention and Control Program, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C. Dr. Niaura is also with the Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore. Dr. Stanton is with Westat, Rockville, Maryland.
authors.forename: Ray
authors.initials: R
authors.lastname: Niaura
mesh_terms: D003695:Delivery of Health Care / Q000379:methods / Q000706:statistics & numerical data*; D015658:HIV Infections / Q000175:diagnosis*; D006297:Health Services Accessibility / Q000706:statistics & numerical data*; D006801:Humans; D016015:Logistic Models; D008691:Methadone / Q000627:therapeutic use; D015999:Multivariate Analysis; D016320:Substance Abuse Treatment Centers / Q000706:statistics & numerical data*; D019966:Substance-Related Disorders / Q000534:rehabilitation*; D011795:Surveys and Questionnaires; D014481:United States
chemical_list: D008691:Methadone